Skip to main content

Stroke FASTEST

Status: Open to Enrollment
Email Us To Enroll

Study Details

View study details on clinicaltrials.gov.

Locations

  • Burlingame

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial

Please contact: fastest@sutterhealth.org about study FASTEST

More information about the study can be found here: https://www.nihstrokenet.org/fastest/home

This research study may affect you or someone you know. Before the research study starts, we will consult with the community. We welcome your feedback and questions. Please click on the survey link below to let us know your thoughts. Thank you!

https://redcap.research.cchmc.org/surveys/?s=YALHC7W838

Ilana Spokoyny
Ilana Spokoyny
Principal investigator
View Profile

Co-investigator

Nobl Barazangi

Email Us to Enroll

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?